Cryoballoon ablation appears to be just as effective as radiofrequency ablation in treating patients with dysplastic Barrett’s esophagus, according to the findings of a new study that may be particularly relevant to endoscopists beginning to use the relatively novel modality.
“The advantage with CBA is that we use the freezing cycle to induce tissue death, and we can pinpoint exactly where the treatment effect goes compared to spray cryotherapy. We think it has better outcomes in terms of side effects, and that it’s better tolerated from a pain perspective,” investigator D. Chamil Codipilly, MD, a clinical gastroenterology and hepatology fellow at Mayo Clinic in Rochester, Minn., told Gastroenterology & Endoscopy News.